HIV Fusion Inhibitors

All categories
DBCAT000220Therapeutic category

Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS. A DrugBank category of 9 drugs. 4 of them are approved.

Also known as
Entry Inhibitors, HIV · Fusion Inhibitors, HIV · HIV Cell Fusion Inhibitors · HIV Entry Inhibitors · HIV Fusion Protein Inhibitors
Drugs

What you can answer from here — as of August 24, 2016

9DrugsEach linked to its full drug card
Listed above
6Drug targetsEvery drug–target pair in the class, with bond type
Sign in
95Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in

Which targets do HIV Fusion Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In